Lab-Grown corneal implant offers hope for advanced keratoconus
NCT ID NCT04653922
First seen Jun 25, 2026 · Last updated Jun 26, 2026 · Updated 1 time
Summary
This early safety study tested a bioengineered corneal implant called LinkCor in 20 adults with advanced keratoconus, a condition that thins and bulges the cornea. The implant is placed inside the cornea to flatten it and improve vision, without needing human donor tissue. Researchers checked for rejection and measured changes in corneal shape and eyesight over six months.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
LinkCor bioengineered corneal implant
What this could lead to
If successful, this implant could offer a less invasive treatment for advanced keratoconus that does not rely on scarce human donor corneas.
What could go wrong
This is a very early, small safety study with only 20 participants. The implant may fail to improve vision or could be rejected, requiring removal.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for KERATOCONUS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
All India Institute of Medical Sciences, Dr. R. P. Centre for Ophthalmic Sciences, AIIMS,
New Delhi, 110029, India
-
Farabi Eye Hospital, Tehran University of Medical Sciences
Tehran, 13366, Iran